Tracking a GLP-1: what to record week to week, how the medication behaves between doses, and how to read your own results alongside it.
A GLP-1 moves slowly enough that no single day tells you much. Here are the six things worth writing down each week, why those six, and how to read what you end up with.
A diary full of paragraphs tells your provider how a day felt; a decision needs to know how days compare. Here are the five columns that make a side-effect log usable — and the evidence on why the night-before catch-up doesn't count.
Compounded GLP-1 vials are labelled in mg/mL, insulin syringes are marked in units and prescribers speak in milligrams — here is how those three scales relate, and why the same amount of drug is a different volume at a different concentration.
Week three on an unchanged GLP-1 schedule is not the same as week one — the FDA labels for semaglutide and tirzepatide explain why levels keep climbing for about a month, then stay for weeks after the last injection.
Lumara is a tracking and education tool. It is not a medical device and does not provide medical advice, diagnosis, or treatment. Always follow your provider's instructions.